Evidence map›Paper›PMID 32618413›Full record

ArticlePediatric blood & cancer2020

Hemoglobin A

Ashley McLean, Frances Wright, Neal deJong, Sarah Skinner, Ceila E Loughlin, Amy Levenson, Marcus A Carden

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Pediatric blood & cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Endocrinopathies in Hemoglobinopathies: What Is the Role of Iron?International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ashley McLeanUniversity of North Carolina School of Medicine, Chapel Hill, North Carolina.
Frances WrightUniversity of North Carolina School of Medicine, Chapel Hill, North Carolina.
Neal deJongUniversity of North Carolina School of Medicine, Chapel Hill, North Carolina.
Sarah SkinnerUniversity of North Carolina School of Medicine, Chapel Hill, North Carolina.
Ceila E LoughlinUniversity of North Carolina School of Medicine, Chapel Hill, North Carolina.
Amy LevensonUniversity of North Carolina School of Medicine, Chapel Hill, North Carolina.
Marcus A CardenUniversity of North Carolina School of Medicine, Chapel Hill, North Carolina.ORCID 0000-0003-3860-3619
University of North Carolina at Chapel Hill · US

Funding

North Carolina Translational and Clinical Science Institute (NC TraCS) KL2KL2TR002490 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WEINBERGER, MORRIS · 2018 to 2022
$11.0M
NCATS NIH HHS KL2 TR002490
6 · The paper itself

Abstract

In patients with sickle cell disease (SCD) and diabetes mellitus (DM), hemoglobin A

Indexed as

AdolescentAnemia, Sickle CellBiomarkersBlood GlucoseBlood TransfusionCystic FibrosisDiabetes MellitusFemaleFructosamineGlycated HemoglobinHumansPrognosisBiomarkersBlood GlucoseFructosamineGlycated Hemoglobinhemoglobin A1c protein, humanchronic transfusion therapycystic fibrosisdiabetes mellitushemoglobin A1cserum fructosaminesickle cell disease

Identifiers

PMID32618413
PMCPMC7674195
OpenAlexW3039606469

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.